The effect of daily administration of trimethoprim (TMP), trimethoprim--sulfamethoxazole (TMP--SMX), or placebo on aerobically grown fecal gram-negative bacteria was monitored in 136 students from the United States during a two-week diarrhea-prevention study in Mexico. Unlike patients in other studies with these agents, who had urinary-tract infection or granulocytopenia, most persons in this study had no change in total fecal Enterobacteriaceae and had high-level TMP and SMX resistance in virtually all these strains. Escherichia coli was the predominant TMP-resistant organism isolated; 96 per cent of 165 TMP-resistant Esch. coli isolates were resistant to at least four antimicrobial agents, and 25 per cent were resistant to seven. TMP resistance was transferable in 40 ot 100 strains tested. Despite the lack of TMP resistance in other studies of prophylaxis, our results clearly demonstrate the remarkable capacity for emergence and dissemination of resistance to this agent.
This article has been cited by other articles:
Qin, X., Razia, Y., Johnson, J. R., Stapp, J. R., Boster, D. R., Tsosie, T., Smith, D. L., Braden, C. R., Gay, K., Angulo, F. J., Tarr, P. I.
(2006). Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.. Antimicrob. Agents Chemother.
50: 3325-3329
[Abstract][Full Text]
Lutter, S. A., Currie, M. L., Mitz, L. B., Greenbaum, L. A.
(2005). Antibiotic Resistance Patterns in Children Hospitalized for Urinary Tract Infections. Arch Pediatr Adolesc Med
159: 924-928
[Abstract][Full Text]
Skurnik, D., Le Menac'h, A., Zurakowski, D., Mazel, D., Courvalin, P., Denamur, E., Andremont, A., Ruimy, R.
(2005). Integron-Associated Antibiotic Resistance and Phylogenetic Grouping of Escherichia coli Isolates from Healthy Subjects Free of Recent Antibiotic Exposure. Antimicrob. Agents Chemother.
49: 3062-3065
[Abstract][Full Text]
DuPont, H. L., Jiang, Z.-D., Okhuysen, P. C., Ericsson, C. D., de la Cabada, F. J., Ke, S., DuPont, M. W., Martinez-Sandoval, F.
(2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea. ANN INTERN MED
142: 805-812
[Abstract][Full Text]
Cremieux, A.-C., Muller-Serieys, C., Panhard, X., Delatour, F., Tchimichkian, M., Mentre, F., Andremont, A.
(2003). Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments. Antimicrob. Agents Chemother.
47: 2030-2035
[Abstract][Full Text]
Sandel, D. C., Wang, C.-T., Kessler, S., Petrof, E. O., Schwartz, D. N., Quinn, J. P., Barlam, T., Moellering, R., Johnson, J. R., Manges, A. R., Riley, L. W.
(2002). Urinary Tract Infections and a Multidrug-Resistant Escherichia coli Clonal Group. NEJM
346: 535-536
[Full Text]
Saux, N. L., Pham, B., Moher, D.
(2000). Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ
163: 523-529
[Abstract][Full Text]
Vila, J., Vargas, M., Ruiz, J., Corachan, M., Jimenez de Anta, M. T., Gascon, J.
(2000). Quinolone Resistance in Enterotoxigenic Escherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas. Antimicrob. Agents Chemother.
44: 1731-1733
[Abstract][Full Text]
Murray, B. E.
(1994). Can Antibiotic Resistance be Controlled?. NEJM
330: 1229-1230
[Full Text]
Previous
